Zhou Y, Yang L
World J Clin Oncol. 2024; 15(9):1239-1244.
PMID: 39351458
PMC: 11438854.
DOI: 10.5306/wjco.v15.i9.1239.
Cui J, Zhao Q, Yu C, Ma P, Li S
Front Oncol. 2024; 14:1369649.
PMID: 39156709
PMC: 11327133.
DOI: 10.3389/fonc.2024.1369649.
Bai L, Guo Y, Song S, Li R, Jiang Y
World J Clin Cases. 2024; 12(21):4783-4788.
PMID: 39070845
PMC: 11235470.
DOI: 10.12998/wjcc.v12.i21.4783.
Gao P, Li X, He Z, Xu Y, Zhang Z
Res Rep Urol. 2024; 16:137-142.
PMID: 38894710
PMC: 11184159.
DOI: 10.2147/RRU.S470653.
Sun Z, Liang X, Zhang C, Song S, Gao J
Front Oncol. 2024; 14:1337997.
PMID: 38529382
PMC: 10961446.
DOI: 10.3389/fonc.2024.1337997.
Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives.
Stumpo S, Formelli M, Persano I, Parlagreco E, Lauricella E, Rodriquenz M
J Clin Med. 2023; 12(24).
PMID: 38137784
PMC: 10743506.
DOI: 10.3390/jcm12247715.
Achieving a one-year-tumor-free survival in a female with primary large cell neuroendocrine carcinoma of the urinary bladder and liver metastasis; a case report.
Mahmoudnejad N, Torbati P, Lashay A, Ahmadi N, Guitynavard F
Urol Case Rep. 2023; 47:102347.
PMID: 36816609
PMC: 9931890.
DOI: 10.1016/j.eucr.2023.102347.
A Case of Bladder Large Cell Carcinoma with Review of the Literature.
Lopedote P, Yosef A, Kozyreva O
Case Rep Oncol. 2022; 15(1):326-337.
PMID: 35529284
PMC: 9035943.
DOI: 10.1159/000521607.
Primary MiNEN of the urinary bladder: an hitherto undescribed entity composed of large cell neuroendocrine carcinoma and adenocarcinoma with a distinct clinical behavior : Description of a case and review of the pertinent literature.
Pini G, Uccella S, Corinti M, Colecchia M, Pelosi G, Patriarca C
Virchows Arch. 2021; 479(1):69-78.
PMID: 33454836
PMC: 8298318.
DOI: 10.1007/s00428-021-03023-7.
Anterior mediastinal large cell neuroendocrine carcinoma with elevated AFP: A case report and review.
Komisarof J, Qiu H, Velez M, Mulford D
Mol Clin Oncol. 2021; 14(2):34.
PMID: 33414915
PMC: 7783711.
DOI: 10.3892/mco.2020.2196.
Clinical Characteristics, Treatment Strategy, and Outcomes of Primary Large Cell Neuroendocrine Carcinoma of the Bladder: A Case Report and Systematic Review of the Literature.
Xia K, Zhong W, Chen J, Lai Y, Huang G, Liu H
Front Oncol. 2020; 10:1291.
PMID: 32850401
PMC: 7399333.
DOI: 10.3389/fonc.2020.01291.
Application of contrast-enhanced ultrasonography for large cell neuroendocrine carcinoma in the urinary bladder: a case report.
Li W, Su Z, Kang J, Xie X, Xie X, Zhuang B
BMC Med Imaging. 2020; 20(1):46.
PMID: 32362278
PMC: 7197184.
DOI: 10.1186/s12880-020-00447-6.
Primary Large-Cell Undifferentiated Carcinoma of the Ureter.
Isikay L, Tonyali S, Aydog G
Med Princ Pract. 2019; 28(5):481-484.
PMID: 30852567
PMC: 6771049.
DOI: 10.1159/000499467.
Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study.
Niu Q, Lu Y, Xu S, Shi Q, Guo B, Guo Z
Cancer Manag Res. 2018; 10:4479-4489.
PMID: 30349380
PMC: 6190820.
DOI: 10.2147/CMAR.S175286.
Rare Occurrence of a Poorly Differentiated Neuroendocrine Tumor of the Bladder.
Dowd K, Rotenberry C, Russell D, Wachtel M, de Riese W
Case Rep Med. 2017; 2017:4812453.
PMID: 28115940
PMC: 5237721.
DOI: 10.1155/2017/4812453.
